Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04270409
Title Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Sanofi
Indications

smoldering myeloma

Therapies

Dexamethasone + Lenalidomide

Dexamethasone + Isatuximab + Lenalidomide

Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.